Patent ID: 7947739

Claim:
A tranexamic acid tablet formulation, comprising: tranexamic acid or a pharmaceutically acceptable salt thereof; and a modified release material, wherein the modified release material comprises a polymer selected from the group consisting of hydroxyalkylcelluloses, alkylcelluloses, cellulose ethers, partial esters thereof, and mixtures thereof; wherein the modified release material is present in the formulation in an amount from about 10% to about 35% by weight of the formulation; wherein the formulation provides an in-vitro dissolution release rate of the tranexamic acid or pharmaceutically acceptable salt thereof, when measured by the USP 27 Apparatus Type II Paddle Method @ 50 RPM in 900 ml water at 37±0.5° C., of less than about 70% by weight tranexamic acid or pharmaceutically acceptable salt thereof released at about 45 minutes, and about 100% by weight tranexamic acid or pharmaceutically acceptable salt thereof released by about 120 minutes; and wherein each tablet of the formulation provides a dose of about 650 mg of tranexamic acid.